MEDI1341
D6340C00002
Phase 1 small_molecule completed
Quick answer
MEDI1341 for Parkinson's Disease is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Parkinson's Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed